Leading pharmaceutical company Lupin Ltd on Wednesday said it was looking at acquiring companies and brands in a bid to strengthen its paediatric business in the US market. "In keeping with our......
Drug firm Lupin Ltd has launched its generic Ciprofloxacin, used for treating bacterial infections, in the American market and is expecting 180 days of market exclusivity. The company's US......
This acquisition marks Lupin's foray into the Japanese branded market in-line with aspirations to build business globally. Kyowa Pharmaceutical Industry, drug major Lupin's Japanese subsidiary, has......
Leading pharmaceutical companies are now making serious attempts to tie up with technology partners to enable their consumers identify genuine products in the market. Drug makers such as Ranbaxy......